Phase II Study of Sunitinib Malate Following Hepatic Artery Embolization
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to decide if a medicine that slows growth of new blood vessels
can be give after the embolization procedure to prevent or delay new growth of blood vessels
to tumors.
Phase:
Phase 2
Details
Lead Sponsor:
H. Lee Moffitt Cancer Center and Research Institute